|
ATE292956T1
(de)
*
|
1998-07-24 |
2005-04-15 |
Seo Hong Yoo |
Klare wässrige lösungen enthaltend gallensäuren
|
|
ES2211184T3
(es)
*
|
1998-08-06 |
2004-07-01 |
Wolfgang Stremmel |
Fosfatidilcolina como medicamento con efecto protector de mucosas.
|
|
UA80667C2
(en)
*
|
1999-09-28 |
2007-10-25 |
Panacea Biotec Ltd |
Controlled release composition comprising nimesulide and process for the preparation thereof
|
|
US7053076B2
(en)
|
2001-08-29 |
2006-05-30 |
Xenoport, Inc. |
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
|
|
US20040131658A1
(en)
*
|
2002-11-01 |
2004-07-08 |
James Kaput |
Identification of diet-regulated disease-associated genes
|
|
JP2010517941A
(ja)
*
|
2007-01-16 |
2010-05-27 |
ザ バーナム インスティテュート フォー メディカル リサーチ |
結腸直腸癌の治療のための組成物および方法
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
KR101890959B1
(ko)
|
2010-11-04 |
2018-08-22 |
알비레오 에이비 |
간질환 치료를 위한 ｉｂａｔ 억제제
|
|
CN106659726A
(zh)
|
2014-06-25 |
2017-05-10 |
Ea制药株式会社 |
固体制剂及其着色防止或着色减少方法
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
CA3071285A1
(en)
|
2017-08-09 |
2019-02-14 |
Albireo Ab |
Cholestyramine granules, oral cholestyramine formulations and use thereof
|
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
CN112449637B
(zh)
|
2018-06-05 |
2024-03-19 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
SG11202012151XA
(en)
|
2018-06-20 |
2021-01-28 |
Albireo Ab |
Crystal modifications of odevixibat
|
|
GB201812382D0
(en)
|
2018-07-30 |
2018-09-12 |
Nzp Uk Ltd |
Compounds
|
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
|
MX2021008981A
(es)
|
2019-02-06 |
2021-09-08 |
Albireo Ab |
Compuestos de benzotiadiazepina y su uso como moduladores del acido biliar.
|
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
CA3158184A1
(en)
|
2019-12-04 |
2021-08-10 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
JP7696898B2
(ja)
|
2019-12-04 |
2025-06-23 |
アルビレオ・アクチボラグ |
ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
|
|
CN114761080B
(zh)
|
2019-12-04 |
2024-07-23 |
阿尔比里奥公司 |
苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
|
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
|
EP4069360B1
(en)
|
2019-12-04 |
2024-01-03 |
Albireo AB |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
ES3002777T3
(en)
|
2020-08-03 |
2025-03-07 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
EP4243831A1
(en)
|
2020-11-12 |
2023-09-20 |
Albireo AB |
Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
|
|
EP4255565A1
(en)
|
2020-12-04 |
2023-10-11 |
Albireo AB |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
TW202313579A
(zh)
|
2021-06-03 |
2023-04-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|